Cutting down
patient wait times
for innovative treatments
Member of the 
Fact
%
of 1st time launcher deliver below expectation
Realize the value of your clinical program in key mature markets
Why a Market-Entry accelerator?
Completing a clinical program is a fantastic achievement, but that does not guarantee access to patients. The ability to deploy commercially is a key part of the value of a biopharma asset. Regulators, Payers, Physicians and patients need to align behind the medical value. A commercial venture requires very different muscles than those of drug development. It is not a risk-free endeavor and must start well ahead of approval.
A Market-Entry accelerator is a perfect fit to find the the way to patients and to morph a clinical-stage organization into a launch-ready organization
Going through the risky entry period through flexible partnering
How xcube.bio works?
Xcube.bio operates on the premise that each partner brings unique strengths to the commercial venture. No one is in a better position than a biopharma innovator to lead the science, medicine, and product manufacturing. Xcube.bio provides market insights, equity, and commercial enablers. The partnership builds progressively, starting with light-touch and flexible advisory upon Phase II. It evolves into the formation of a NewCo to navigate the market entry. At maturity, biopharma originator holds the option to fully owned the NewCo.
Xcube.bio develops a co-owned NewCo, enabling the market-entry operations and offering favorable risk/benefit balance to the biopharma partner.
Benefit from an end-to-end market entry platform
What does xcube offer?
A successful territory expansion starts with right advisory, but it’s just the beginning. Entering new market also requires precise decision-making, dedicated financing, and flawless execution within a high-performing launch ecosystem. At Xcube.bio, we leverage an end-to-end launchpad and operating platform to facilitate patient access to each of our NewCo.
Fast-track the path to patients, empower your launch plan, and optimize costs with Xcube.bio’s integrated platform
Decision support
Bridge management
Expansion equity
End-to-end launchpad
Hands-on and invested in the mission.
Who are we?
Xcube.bio comprises a diverse team of over 40 hands-on industry experts catering to innovators’ needs with incentives aligned with NewCo success. Our expertise goes from launch and market access experts to organization builders and supply chain advisors, and from medical to financial capabilities.
We have already succeeded in what we offer within biopharma organizations.
Let’s start the conversation
How to connect?
There is so much more we can share and so many solutions to explore. Let’s schedule a touch point to discuss your ambition.
Latest News
You can also find xcube.bio’s events and news on Linkedin.
Eder Therapeutics and xcube.bio Announce Strategic Partnership for Biotech Market Access in Europe and Canada
Eder Therapeutics and xcube.bio have announced a strategic cooperation to facilitate the market entry and commercialization of biotech assets in Canada and Europe. The two companies will coordinate their offerings to biopharma innovators in their respective regions...
« Turbulence is life force », a personal take on FierceBiotech Summit 2023
xcube turbulence is lifeforce article October 2023-2